Country: Bretland
Tungumál: enska
Heimild: MHRA (Medicines & Healthcare Products Regulatory Agency)
Mannitol
20%) infusion Viaflex bags (Baxter Healthcare Ltd
B05BC01
Mannitol
200mg/1ml
Infusion
Intravenous
No Controlled Drug Status
Valid as a prescribable product
BNF: 02020500; GTIN: 5413760020235
OBJECT 1 MANNITOL INTRAVENOUS INFUSION EP 20% W/V Summary of Product Characteristics Updated 02-Aug-2016 | Baxter Healthcare Ltd 1. Name of the medicinal product Mannitol Intravenous Infusion EP 20% w/v 2. Qualitative and quantitative composition Mannitol EP 200.00gm 3. Pharmaceutical form A sterile non-pyrogenic Intravenous Infusion for administration to human beings. 4. Clinical particulars 4.1 Therapeutic indications 1. The promotion of diuresis in the prevention of and/or treatment of the oliguric phase of acute renal failure before irreversible renal failure becomes established. 2. The reduction of intracranial pressure and the treatment of cerebral oedema. 3. The reduction of elevated intraocular pressure when the pressure cannot be lowered by other means. 4. Promoting the urinary excretion of toxic substances such as aspirin and barbiturates. 4.2 Posology and method of administration The dose range for adults is 50 to 200gm in a 24 hr period with a dosage limit of 50gm on any one occasion. In most instances an adequate response will be achieved at a dosage of approximately 100gm per 24hr period. The rate of administration is usually adjusted to maintain a urine flow of at least 30-50ml per hour. The dosage requirements for patients 12 years of age and under have not been established. Treatment of oliguria: the usual dose is 100gm of Mannitol administered as a 15% w/v or 20% w/v solution. Reduction of intraocular pressure: a dose of 1.5 to 2.0gm per kg of body weight may be given, as a 15% w/v or 20% w/v solution, over a period as short as 30 minutes in order to obtain a prompt and maximal effect. When used preoperatively, the dose should be given 1-1.5 hours before surgery to obtain the maximum effect. An infusion of 50 to 100gm of Mannitol may be given during cardiovascular and other types of surgery as an aid in preventing acute renal failure. The concentration and volume to be administered will depend upon the fluid requirement of the patient. 4.3 Contraindications 1. Well-established anuria due to seve Lestu allt skjalið